Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease

Background and objectivesLittle is known about the prevalence of anxiety in interstitial lung disease (ILD), and the contributors to depression are not clear. The aim of this study was to determine the prevalence and predictors of anxiety and depression in people with ILD. MethodsOne hundred and twenty-four individuals with ILD (age 64 years (standard deviation 12), 48 idiopathic pulmonary fibrosis) participated. Anxiety and depression were assessed using the Hospital Anxiety and Depression Scale to determine likely cases and borderline cases. Associations with demographic data, respiratory function, 6-min walk and Modified Medical Research Council Dyspnoea Scale (MMRC) were examined. ResultsThe prevalence of anxiety was 31%, with clinically significant anxiety in 12%. Depression was present in 23% of individuals, with 7% having clinically significant depression. Independent predictors of anxiety were a higher MMRC score (P=0.005, odds ratio (OR) for case 2.60, 95% confidence interval 1.37 to 4.92) and higher nadir SpO(2) during walking (P=0.003, OR for case 1.16, 1.04-1.30). Independent predictors of depression were a higher MMRC score (P=0.006, case OR 3.84, 1.25-11.78, borderline case OR 2.44, 1.14-5.19) and a greater number of comorbidities (P=0.003, case OR 2.02, 0.97-4.21, borderline case OR 2.26, 1.30-3.93). ConclusionsAnxiety and depression are present in a significant minority of individuals with ILD. Dyspnoea and comorbidities are important contributors that may be amenable to intervention. The prevalence of anxiety and the contributing factors to depression in ILD were evaluated. Anxiety and depression were comorbidities in a significant minority of individuals. Functional dyspnoea and a higher number of comorbidities contributed to depression.